Published in Cancer Weekly, October 24th, 2000
The Levulan PDT System is the first to use light-activated drugs to treat these common skin lesions. Distribution of the Levulan PDT System will begin immediately.
The active ingredient in the Levulan PDT System is aminolevulinic acid (ALA). This new...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.